Van beleggers
voor beleggers
desktop iconMarkt Monitor
  • Word abonnee
  • Inloggen

    Inloggen

    • Geen account? Registreren

    Wachtwoord vergeten?

Ontvang nu dagelijks onze kooptips!

word abonnee

CRUCELL KONDIGT PER.C6-LICENTIEOVEREENKOMST

4 Posts
| Omlaag ↓
  1. [verwijderd] 15 maart 2007 14:09
    Crucell Announces PER.C6® Licensing Agreement with Pfizer Animal Health




    Leiden, The Netherlands, March 15, 2007- Dutch biotechnology company Crucell N.V. (Euronext, NASDAQ: CRXL; Swiss Exchange: CRX) and Pfizer Animal Health today announced the signing of a research license agreement for PER.C6®. The license agreement allows Pfizer Animal Health to use Crucell's industry-leading PER.C6® cell technology in the production of a non-disclosed veterinary vaccine. Pfizer Animal Health has an option to convert the research license into a commercial agreement. Financial details were not disclosed.

4 Posts
|Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met je emailadres en wachtwoord.

Direct naar Forum

Indices

AEX 910,09 -0,53%
EUR/USD 1,0859 +0,01%
FTSE 100 8.382,08 -0,50%
Germany40^ 18.679,20 -0,48%
Gold spot 2.426,79 +0,02%
NY-Nasdaq Composite 16.794,87 +0,65%

Stijgers

Flow T...
+1,74%
SBM Of...
+1,73%
INPOST
+1,29%
OCI
+1,08%
RENEWI
+0,67%

Dalers

Alfen ...
-15,17%
Sif Ho...
-5,16%
FASTNED
-4,29%
AMG Cr...
-4,04%
Avantium
-3,68%

Lees verder op het IEX netwerk Let op: Artikelen linken naar andere sites

Gesponsorde links